BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 35485425)

  • 1. The TOX subfamily: all-round players in the immune system.
    Han J; Wan M; Ma Z; He P
    Clin Exp Immunol; 2022 Jun; 208(3):268-280. PubMed ID: 35485425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role, function and regulation of the thymocyte selection-associated high mobility group box protein in CD8
    Cheng Y; Shao Z; Chen L; Zheng Q; Zhang Q; Ding W; Zhang M; Yu Q; Gao D
    Immunol Lett; 2021 Jan; 229():1-7. PubMed ID: 33186634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TOX promotes the exhaustion of antitumor CD8
    Wang X; He Q; Shen H; Xia A; Tian W; Yu W; Sun B
    J Hepatol; 2019 Oct; 71(4):731-741. PubMed ID: 31173813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of TOX in the Development of Innate Lymphoid Cells.
    Seehus CR; Kaye J
    Mediators Inflamm; 2015; 2015():243868. PubMed ID: 26556952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-mobility group box (TOX) antibody a useful tool for the identification of B and T cell subpopulations.
    Maestre L; García-García JF; Jiménez S; Reyes-García AI; García-González Á; Montes-Moreno S; Arribas AJ; González-García P; Caleiras E; Banham AH; Piris MÁ; Roncador G
    PLoS One; 2020; 15(2):e0229743. PubMed ID: 32106280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased TOX expression concurrent with PD-1, Tim-3, and CD244 expression in T cells from patients with acute myeloid leukemia.
    Huang S; Liang C; Zhao Y; Deng T; Tan J; Zha X; Li Y; Chen S
    Cytometry B Clin Cytom; 2022 Mar; 102(2):143-152. PubMed ID: 34913594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TOX correlates with prognosis, immune infiltration, and T cells exhaustion in lung adenocarcinoma.
    Guo L; Li X; Liu R; Chen Y; Ren C; Du S
    Cancer Med; 2020 Sep; 9(18):6694-6709. PubMed ID: 32700817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TOX is expressed by exhausted and polyfunctional human effector memory CD8
    Sekine T; Perez-Potti A; Nguyen S; Gorin JB; Wu VH; Gostick E; Llewellyn-Lacey S; Hammer Q; Falck-Jones S; Vangeti S; Yu M; Smed-Sörensen A; Gaballa A; Uhlin M; Sandberg JK; Brander C; Nowak P; Goepfert PA; Price DA; Betts MR; Buggert M
    Sci Immunol; 2020 Jul; 5(49):. PubMed ID: 32620560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-cell transcriptome analysis reveals TOX as a promoting factor for T cell exhaustion and a predictor for anti-PD-1 responses in human cancer.
    Kim K; Park S; Park SY; Kim G; Park SM; Cho JW; Kim DH; Park YM; Koh YW; Kim HR; Ha SJ; Lee I
    Genome Med; 2020 Feb; 12(1):22. PubMed ID: 32111241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased TOX expression concurrent with PD-1, Tim-3, and CD244 in T cells from patients with non-Hodgkin lymphoma.
    Huang S; Liang C; Zhao Y; Deng T; Tan J; Lu Y; Liu S; Li Y; Chen S
    Asia Pac J Clin Oncol; 2022 Feb; 18(1):143-149. PubMed ID: 33608984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TOX-expressing terminally exhausted tumor-infiltrating CD8
    Han HS; Jeong S; Kim H; Kim HD; Kim AR; Kwon M; Park SH; Woo CG; Kim HK; Lee KH; Seo SP; Kang HW; Kim WT; Kim WJ; Yun SJ; Shin EC
    Cancer Lett; 2021 Feb; 499():137-147. PubMed ID: 33249194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymocyte selection-associated high mobility box protein regulates T lymphocytes exhaustion in patients with myelodysplastic syndromes by inhibiting PI3K/AKT/mTOR pathway.
    Niu H; Zhang M; Liu M; Yang L; Yang L; Ren J; Yu Y; Liu Y; Xing L; Shao Z; Wang H
    Hematol Oncol; 2024 Jan; 42(1):e3224. PubMed ID: 37712442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TOX promotes follicular helper T cell differentiation in patients with primary Sjögren's syndrome.
    Liu S; Yang Y; Zeng L; Wang L; He C; Chen Z; Sun J; Lyu T; Wang M; Chen H; Zhang F
    Rheumatology (Oxford); 2023 Feb; 62(2):946-957. PubMed ID: 35713502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The many roles of TOX in the immune system.
    Aliahmad P; Seksenyan A; Kaye J
    Curr Opin Immunol; 2012 Apr; 24(2):173-7. PubMed ID: 22209117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TOX regulates the differentiation of human natural killer cells from hematopoietic stem cells in vitro.
    Yun S; Lee SH; Yoon SR; Kim MS; Piao ZH; Myung PK; Kim TD; Jung H; Choi I
    Immunol Lett; 2011 Apr; 136(1):29-36. PubMed ID: 21126536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory signals are sufficient to elicit TOX expression in mouse and human CD8+ T cells.
    Maurice NJ; Berner J; Taber AK; Zehn D; Prlic M
    JCI Insight; 2021 Jul; 6(13):. PubMed ID: 34032638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TOX expression in cutaneous T-cell lymphomas: an adjunctive diagnostic marker that is not tumour specific and not restricted to the CD4(+)  CD8(-) phenotype.
    Schrader AM; Jansen PM; Willemze R
    Br J Dermatol; 2016 Aug; 175(2):382-6. PubMed ID: 26931394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shared dependence on the DNA-binding factor TOX for the development of lymphoid tissue-inducer cell and NK cell lineages.
    Aliahmad P; de la Torre B; Kaye J
    Nat Immunol; 2010 Oct; 11(10):945-52. PubMed ID: 20818394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High TOX expression on CD8
    Niu H; Yan L; Yang L; Zhang M; Liu M; Ren J; Shao Z; Fu R; Xing L; Wang H
    Ann Hematol; 2023 May; 102(5):1247-1255. PubMed ID: 36933041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal Cancer-Associated Immune Exhaustion Involves T and B Lymphocytes and Conventional NK Cells and Correlates With a Shorter Overall Survival.
    Sorrentino C; D'Antonio L; Fieni C; Ciummo SL; Di Carlo E
    Front Immunol; 2021; 12():778329. PubMed ID: 34975867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.